Accueil   Diary - News   All news MaaT Pharma Presents Product Analysis

MaaT Pharma Presents Product Analysis

 

MaaT Pharma Presents Product Analysis of its First-in-class High Diversity Microbiome Therapeutic at 2018 EMBO Symposium on The Human Microbiome
 

Results from in silico analysis using MaaT Pharma’s data analysis platform, GutPrint, demonstrate therapeutic rationale and manufacturing capabilities of developing a high diversity biological drug product.

 

 

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree